COMP <GO>
FLR vs TMO // RETURN ON INVESTED CAPITAL (ROIC)
Fluor Corporation (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: FLR 2
— TMO 12
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: TMO
LAST: $46.86 (-1.47%) • MKT CAP: $6.36B
roic
-13.70%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
roic
9.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FLR VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FLR | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | -0.80% | 41.00% | -41.80 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -13.70% | 9.30% | -23.00 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 30.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -6.87% | 2.40% | -9.27 | TMO | /fcf-yield <GO> |
| Operating Margin | -2.40% | 17.40% | -19.80 | TMO | /operating-margins <GO> |
| Net Profit Margin | -0.30% | 15.10% | -15.40 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | -5.00% | 3.90% | -8.90 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.66 | 4.50 | -0.84 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 8/9 | -6.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 6.70% | -0.10 | FLR | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.7 | 59.1 | -14.47 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | 0.94 | -0.04 | TMO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.0x | 36.3x | -15.30 | FLR | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.36B | $262.22B | -$255.86B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FLR REV | TMO REV | FLR GROSS % | TMO GROSS % | FLR FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $15.50B | $44.56B | -0.8% | 44.0% | -$437.0M | $6.29B |
| FY 2024 | $16.32B | $42.88B | 3.5% | 44.0% | $664.0M | $7.27B |
| FY 2023 | $15.47B | $42.86B | 44.0% | 44.0% | -$484.3M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FLR // BETA 0.90
TMO // BETA 0.94